title: Multiple sclerosis, immunomodulation, and immunizations: balancing the benefits.
authors: From the Department of Neurology (M.D.G.), University of Virginia, Charlottesville; and the Department of Neurology (R.T.N.), Washington University, St. Louis, MO. mdg3n@virginia.edu.
authors: Myla D
authors: MD
authors: Goldman
authors: From the Department of Neurology (M.D.G.), University of Virginia, Charlottesville; and the Department of Neurology (R.T.N.), Washington University, St. Louis, MO.
authors: Robert T
authors: RT
authors: Naismith
mesh_terms: D005260:Female; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007252:Influenza Vaccines / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011409:Propylene Glycols / Q000627:therapeutic use*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014611:Vaccination
chemical_list: D007166:Immunosuppressive Agents; D007252:Influenza Vaccines; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine